Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
更正：一项随机、开放标签、适应性、概念验证性临床试验，旨在研究调节 COVID-19 患者宿主血栓炎症反应：DAWn-Antico 研究
期刊:Trials
影响因子:2
doi:10.1186/s13063-020-04991-y
Vanassche, T; Engelen, M M; Van Thillo, Q; Wauters, J; Gunst, J; Wouters, C; Vandenbriele, C; Rex, S; Liesenborghs, L; Wilmer, A; Meersseman, P; Van den Berghe, G; Dauwe, D; Verbeke, G; Thomeer, M; Fivez, T; Mesotten, D; Ruttens, D; Heytens, L; Dapper, I; Tuyls, S; De Tavernier, B; Verhamme, P
